◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

PharmaCorp Rx Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 5.8M 0.00 0.00 --
Operating Revenue 5.8M 0.00 0.00 --
Cost Of Revenue 3.6M 0.00 -- --
Gross Profit 2.2M 0.00 -- --
Selling General And Administration 3.5M 577,960 563,177 --
General And Administrative Expense 3.5M 577,960 563,177 --
Depreciation And Amortization In Income Statement 289,874 0.00 -- --
Operating Expense 3.8M 577,960 563,177 --
Operating Income -1.6M -577,960 -563,177 --
EBIT -1.1M -470,428 -563,177 --
Interest Expense 32,434 0.00 -- --
Interest Expense Non Operating 32,434 0.00 -- --
Interest Income 381,248 107,532 46,092 --
Interest Income Non Operating 381,248 107,532 46,092 --
Net Interest Income 348,814 107,532 46,092 --
Other Income Expense 82,133 -- -- --
Other Non Operating Income Expenses 82,133 -- -- --
Pretax Income -1.2M -470,428 -517,085 --
Tax Provision -106,451 0.00 -- --
Tax Effect Of Unusual Items 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -1.1M -470,428 -517,085 --
Net Income From Continuing Operation Net Minority Interest -1.1M -470,428 -517,085 --
Net Income Including Noncontrolling Interests -1.1M -470,428 -517,085 --
Net Income Common Stockholders -1.1M -470,428 -517,085 --
Net Income -1.1M -470,428 -517,085 --
EBITDA -835,078 -470,428 -563,177 --
Normalized EBITDA -835,078 -470,428 -563,177 --
Reconciled Depreciation 289,874 0.00 -- --
Basic EPS -0.01 -0.01 -0.02 --
Diluted EPS -0.01 -0.01 -0.02 --
Basic Average Shares 81.7M 40.3M 32.5M --
Diluted Average Shares 81.7M 40.3M 32.5M --
Tax Rate For Calcs 0.09 0.00 0.00 --
Normalized Income -1.1M -470,428 -517,085 --
Depreciation Amortization Depletion Income Statement 289,874 0.00 -- --
Depreciation Income Statement 289,874 0.00 -- --
Diluted NI Availto Com Stockholders -1.1M -470,428 -517,085 --
Net Income Continuous Operations -1.1M -470,428 -517,085 --
Net Non Operating Interest Income Expense 348,814 107,532 46,092 --
Other Gand A 1.9M 577,960 176,897 --
Reconciled Cost Of Revenue 3.6M 0.00 -- --
Salaries And Wages 1.6M 0.00 386,280 --
Total Expenses 7.4M 577,960 563,177 --
Total Operating Income As Reported -1.6M -577,960 -- --
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 12.9M 2.2M 2.7M 980,025
Cash Cash Equivalents And Short Term Investments 12.9M 2.2M 2.7M 980,025
Cash Financial 12.9M 2.2M -- --
Accounts Receivable 326,783 0.00 -- --
Receivables 326,783 0.00 -- --
Inventory 1.3M 0.00 -- --
Prepaid Assets 48,026 0.00 -- --
Current Assets 14.6M 2.3M 2.7M 1.0M
Gross PPE 4.1M 0.00 -- --
Accumulated Depreciation -69,779 0.00 -- --
Net PPE 4.0M 0.00 -- --
Goodwill 11.5M 0.00 -- --
Goodwill And Other Intangible Assets 16.6M 0.00 -- --
Other Intangible Assets 5.1M -- -- --
Total Non Current Assets 20.6M 0.00 0.00 0.00
Total Assets 35.2M 2.3M 2.7M 1.0M
Current Debt 75,412 -- -- --
Current Debt And Capital Lease Obligation 149,384 -- -- --
Accounts Payable 1.5M 46,185 16,465 26,343
Payables 1.5M 46,185 16,465 26,343
Payables And Accrued Expenses 1.5M 46,185 16,465 26,343
Current Liabilities 1.7M 46,185 16,465 26,343
Long Term Debt 318,206 -- -- --
Long Term Debt And Capital Lease Obligation 803,693 0.00 -- --
Long Term Capital Lease Obligation 485,487 0.00 -- --
Other Non Current Liabilities -1,000 -- -- --
Total Non Current Liabilities Net Minority Interest 2.9M 0.00 0.00 0.00
Total Liabilities Net Minority Interest 4.6M 46,185 16,465 26,343
Common Stock 31.7M 2.8M 2.7M 1.0M
Capital Stock 31.7M 2.8M 2.7M 1.0M
Additional Paid In Capital 674,733 488,792 516,632 0.00
Retained Earnings -2.0M -1.0M -542,903 -25,818
Common Stock Equity 30.3M 2.3M 2.7M 974,182
Stockholders Equity 30.3M 2.3M 2.7M 974,182
Total Equity Gross Minority Interest 30.6M 2.3M 2.7M 974,182
Minority Interest 222,483 0.00 -- --
Total Capitalization 30.7M 2.3M 2.7M 974,182
Net Tangible Assets 13.7M 2.3M 2.7M 974,182
Tangible Book Value 13.7M 2.3M 2.7M 974,182
Working Capital 12.9M 2.3M 2.7M 974,182
Invested Capital 30.7M 2.3M 2.7M 974,182
Total Debt 953,077 0.00 -- --
Share Issued 117.3M 40.3M 40.0M 40.0M
Ordinary Shares Number 117.3M 40.3M 40.0M 40.0M
Buildings And Improvements 3.4M 0.00 -- --
Capital Lease Obligations 559,459 0.00 -- --
Current Capital Lease Obligation 73,972 0.00 -- --
Current Deferred Assets 0.00 78,750 0.00 20,500
Land And Improvements 270,275 0.00 -- --
Leases 309,067 0.00 -- --
Machinery Furniture Equipment 127,447 0.00 -- --
Non Current Deferred Liabilities 2.1M 0.00 -- --
Non Current Deferred Taxes Liabilities 2.1M 0.00 -- --
Other Current Borrowings 75,412 -- -- --
Other Inventories 1.3M -- -- --
Properties 0.00 0.00 -- --
Raw Materials 44,254 0.00 -- --
Total Tax Payable 10,521 0.00 -- --
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow 124,968 -519,458 -120,183 --
Cash Flow From Continuing Operating Activities 124,968 -519,458 -120,183 --
Depreciation And Amortization 289,874 0.00 -- --
Depreciation Amortization Depletion 289,874 0.00 -- --
Stock Based Compensation 283,154 0.00 386,280 --
Deferred Tax -137,637 0.00 -- --
Deferred Income Tax -137,637 0.00 -- --
Change In Working Capital 708,078 -49,030 10,622 --
Change In Payables And Accrued Expense -- 29,720 -9,878 --
Change In Other Working Capital -- -78,750 20,500 --
Other Non Cash Items 32,434 -- -- --
Capital Expenditure -6,890 -- -- --
Purchase Of PPE -6,890 0.00 -- --
Net PPE Purchase And Sale -6,890 0.00 -- --
Purchase Of Business -16.9M -- -- --
Investing Cash Flow -16.9M 0.00 -- --
Cash Flow From Continuing Investing Activities -16.9M 0.00 -- --
Repayment Of Debt -107,077 0.00 -- --
Net Issuance Payments Of Debt -107,077 0.00 -- --
Issuance Of Capital Stock 27.3M 27,840 2.0M --
Net Common Stock Issuance 27.3M 27,840 2.0M --
Financing Cash Flow 27.4M 27,840 1.9M --
Cash Flow From Continuing Financing Activities 27.4M 27,840 1.9M --
Changes In Cash 10.6M -491,618 1.8M --
Beginning Cash Position 2.2M 2.7M 980,025 --
End Cash Position 12.9M 2.2M 2.7M --
Free Cash Flow 118,078 -519,458 -120,183 --
Cash Dividends Paid -- -- 0.00 --
Common Stock Issuance 27.3M 27,840 2.0M --
Interest Paid Cff -- -- 0.00 --
Long Term Debt Payments -107,077 0.00 -- --
Net Business Purchase And Sale -16.9M -- -- --
Net Income From Continuing Operations -1.1M -470,428 -517,085 --
Net Long Term Debt Issuance -107,077 0.00 -- --
Net Other Financing Charges -- -- -126,463 --
Proceeds From Stock Option Exercised 163,260 0.00 -- --
NEWS
Loading news...
TRENDING
Loading...